Phase 1 study of KX01 Ointment 1% in Japanese healthy male subjects

Skin Irritation and Phototoxicity Study of KX01 Ointment 1% in Japanese healthy male subjects

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2031210434

Enrollment

Registered

2021-11-19

Start date

2021-11-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Actinic keratosis

Interventions

Apply KX01 ointment 1%

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Healthy Japanese male adult, whose age 20-65 years old

Exclusion criteria

Exclusion criteria: History of photosensitivity or photoallergy

Design outcomes

Primary

Measure	Time frame
Safety, e.g. AE, evaluation	—

Contacts

Public ContactHiroaki Kawase

PharmaEssentia Japan KK

hiroaki_kawase@pharmaessentia.com+81-3-6910-5103

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026